10 results about "Biological substances" patented technology

Provided herein is a biological substance treatment method in which a flow cell is prepared, the flow cell including a chamber array device including a plurality of chambers and a cover body defining a flow path communicating with an opening of the plurality of chambers and provided in common for the plurality of chambers.

There is provided a particle for the immunoagglutination assay that is a particle for immunoagglutination assay, which includes a diamond particle and a ligand that specifically binds to a biological substance. The ligand is immobilized to the diamond particle, and the particle for the immunoagglutination assay has a particle size of 50 nm or more and 1,000 nm or less.

A biological substance cumulative amount measurement device 1 for measuring a cumulative amount of a biological substance generated in a living body, said device including: a biofuel cell 20 for generating power using a specific biological substance 13 as a substrate; a power storage unit 40 for storing electric energy generated through power generation by the biofuel cell 20; and a communication unit 50 for outputting information on the electric energy stored in the power storage unit 40 in response to a trigger from the outside.

The excitation light source (1) emits excitation light that advances in the optical medium (3) toward the sample (5) placed on the sample placement surface. The probe light source (2) emits probe light advancing in the optical medium (3). The light position detector (4) detects the position of the emitted probe light emitted from the optical medium (3). The arithmetic unit (11) calculates the position of the probe light emitted by the light position detector (4) when the sample (5) is a reference substance that absorbs the excitation light and does not have a specific absorption peak within the excitation wavelength of the excitation light, and the position of the probe light emitted by the light position detector (4) when the sample (5) is a biological substance. The amount or concentration of the biological component in the biological substance is calculated.

The invention relates to the technical field of veterinary drugs, in particular to a composition for preventing and / or treating donkey mastitis and application thereof. The invention provides a composition for preventing and / or treating donkey mastitis. The composition comprises the following components: nisin, lysozyme, a honeysuckle extract, a dandelion extract, a lithospermum extract, an astragalus extract and a frankincense extract. The composition can effectively prevent and / or treat donkey mastitis, the active ingredients of the composition are natural or biogenic substances, the antibacterial mechanism of the composition is unique, bacteria are not easily induced to generate drug resistance, and the composition is safe and free of residues, meets the urgent needs of green, healthy and sustainable development of animal husbandry, and has remarkable clinical application value and wide market prospects.

To solve ethical and sanitary problems in a simulated thrombus and to improve the elasticity of the simulated thrombus.SOLUTION: The simulated thrombus includes a gel-like blood portion containing simulated blood made of a non-biological substance as a main component, and graphite powder contained in the blood portion.SELECTED DRAWING: Figure 3

A device for measuring electrical conductivity of target ("Target") comprising blood, a body fluid, a body tissue, a biological substance, a liquid or a solid material, comprising a hollow body having a closed end and an open end; a triboelectric nanogenerator (TENG) disposed within the hollow body; the TENG comprising first and second discs disposed within the hollow body, wherein the first disc is disposed adjacent to the closed end of the hollow body and the second disc is spaced apart from the first disc to define a target chamber within the hollow body; a third disc spaced apart from the second disc towards the open end to define a gap between the second and third discs; a first electrode comprising an electrically conductive material disposed on a side of the third disc opposite the gap; and a second electrode comprising a Target in the target chamber.

The utility model discloses a monitoring device for an intake salt meter of a hypertensive patient, and relates to the technical field of biological substances such as blood and urine. The monitoring device comprises a display, the right side of the display is fixedly connected with a fixing block, the right side of the fixing block is provided with a storage groove, the left side of the storage groove penetrates through the fixing block, a supporting plate is installed in the storage groove, and the upper side and the lower side of the supporting plate are both semi-cylindrical surfaces. A storage groove is formed in the upper portion of the fixing block, a check block is connected into the storage groove, the left side of the check block is fixedly connected with the displayer, the check block is arranged at the position close to the lower side, the right side of the displayer is fixedly connected with a containing shell, and a control mechanism is arranged in the fixing block. And therefore, the display can be supported and fixed on different objects, and meanwhile, the stability after supporting can be ensured, so that the application range of the device is widened.

To provide a reaction device capable of maintaining the same dispensing amount accuracy of a chemical liquid between a plurality of array plates.SOLUTION: A reaction device for producing a reaction product of a living body-derived material contained in a spot on an array plate and a target material in a sample liquid includes a container placement section on which a reaction container including the array plate is placed, a chemical solution placement section on which a chemical solution container containing a chemical solution is placed, a pipetter to which a pipette tip is attached and which the chemical solution from the chemical solution container and dispenses the chemical solution into the reaction container, and a control section that changes a dispensing operation of the pipetter according to at least any of a type of the chemical solution, a state of the chemical solution, an operation history of the pipetter, and a state of the pipette tip.SELECTED DRAWING: Figure 1

The application discloses a preparation method of a material for enriching hydrophilic biological substances, and the core of the method is to perform peptide segment enrichment through specific binding of chemically modified magnetic nanoparticles and glycosylated peptide segments, so that the problems of high cost, complicated operation and limited identification throughput are solved, and an efficient, stable and easy-to-operate technical process is provided for glycoproteomics research. High selectivity: the surface of the magnetic beads is a combination of mesoporous structures and quaternary ammonium salt groups, which significantly improves the selectivity of the glycosylated peptide segments and reduces non-specific adsorption. The number of N-glycans can be identified to an average of 2733, and the number of O-glycans can be identified to an average of 1777. Simple operation: the introduction of the magnetic beads simplifies the enrichment process and facilitates subsequent automated experiments and large-scale applications. Cost reduction: by simplifying the synthesis method and improving the stability of the material, the preparation and application cost of the material is reduced.